Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Marcel Bally

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Living Beings

Anatomy

Tumor Cell Line

Concepts & Ideas

Hydrogen-Ion Concentration

Procedures

Devices

Drug Delivery Systems

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
47
Mayer, Lawrence
32
Cullis, Pieter
24
Masin, Dana
18
Waterhouse, Dawn
16
Madden, Thomas
15
Dragowska, Wieslawa
12
Gelmon, Karen
10
Webb, Murray
9
Wasan, Ellen
9
Tardi, Paul
9
Edwards, Katarina
9
Karlsson, Göran
9
Harasym, Troy
8
Abraham, Sheela
8
Chiu, Gigi

Sign-in to see all Coauthors

Publications

TOP 3
Musende Alain G; Eberding Andy; Wood Catherine; Adomat Hans; Fazli Ladan; Hurtado-Coll Antonio; Jia William; Bally Marcel B; Guns Emma Tomlinson
Pre-clinical evaluation of Rh2 in PC-3 human xenograft model for prostate cancer in vivo: formulation, pharmacokinetics, biodistribution and efficacy.
Verreault Maite; Bally Marcel B
siRNA-mediated integrin-linked kinase suppression: nonspecific effects of siRNA/cationic liposome complexes trigger changes in the expression of phosphorylated-AKT and mTOR independently of ILK silencing.
Baker Jennifer H E; Lam Jeffrey; Kyle Alaistair H; Sy Jonathan; Oliver Thomas; Co Steven J; Dragowska Wieslawa H; Ramsay Euan; Anantha Malathi; Ruth Thomas J; Adam Michael J; Yung Andrew; Kozlowski Piotr; Minchinton Andrew I; Ng Sylvia S W; Bally Marcel B; Yapp Donald T T
Irinophore C, a novel nanoformulation of irinotecan, alters tumor vascular function and enhances the distribution of 5-fluorouracil and doxorubicin.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Marcel Bally (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Musende Alain G; Eberding Andy; Wood Catherine; Adomat Hans; Fazli Ladan; Hurtado-Coll Antonio; Jia William; Bally Marcel B; Guns Emma Tomlinson
Pre-clinical evaluation of Rh2 in PC-3 human xenograft model for prostate cancer in vivo: formulation, pharmacokinetics, biodistribution and efficacy.
Cancer chemotherapy and pharmacology 2009;64(6):1085-95.
2009: Verreault Maite; Bally Marcel B
siRNA-mediated integrin-linked kinase suppression: nonspecific effects of siRNA/cationic liposome complexes trigger changes in the expression of phosphorylated-AKT and mTOR independently of ILK silencing.
Oligonucleotides 2009;19(2):129-40.
2008: Baker Jennifer H E; Lam Jeffrey; Kyle Alaistair H; Sy Jonathan; Oliver Thomas; Co Steven J; Dragowska Wieslawa H; Ramsay Euan; Anantha Malathi; Ruth Thomas J; Adam Michael J; Yung Andrew; Kozlowski Piotr; Minchinton Andrew I; Ng Sylvia S W; Bally Marcel B; Yapp Donald T T
Irinophore C, a novel nanoformulation of irinotecan, alters tumor vascular function and enhances the distribution of 5-fluorouracil and doxorubicin.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(22):7260-71.
2008: Tucker Catherine A; Kapanen Anita I; Chikh Ghania; Hoffman Brad G; Kyle Alastair H; Wilson Ian M; Masin Dana; Gascoyne Randy D; Bally Marcel; Klasa Richard J
Silencing Bcl-2 in models of mantle cell lymphoma is associated with decreases in cyclin D1, nuclear factor-kappaB, p53, bax, and p27 levels.
Molecular cancer therapeutics 2008;7(4):749-58.
2008: McDonald Paul C; Oloumi Arusha; Mills Julia; Dobreva Iveta; Maidan Mykola; Gray Virginia; Wederell Elizabeth D; Bally Marcel B; Foster Leonard J; Dedhar Shoukat
Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survival.
Cancer research 2008;68(6):1618-24.
2008: Ramsay Euan; Alnajim Jehan; Anantha Malathi; Zastre Jason; Yan Hong; Webb Murray; Waterhouse Dawn; Bally Marcel
A novel liposomal irinotecan formulation with significant anti-tumour activity: use of the divalent cation ionophore A23187 and copper-containing liposomes to improve drug retention.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2008;68(3):607-17.
2008: Ramsay Euan C; Anantha Malathi; Zastre Jason; Meijs Marieke; Zonderhuis Jet; Strutt Dita; Webb Murray S; Waterhouse Dawn; Bally Marcel B
Irinophore C: a liposome formulation of irinotecan with substantially improved therapeutic efficacy against a panel of human xenograft tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(4):1208-17.
2008: Woo Janet; Chiu Gigi N C; Karlsson Göran; Wasan Ellen; Ickenstein Ludger; Edwards Katarina; Bally Marcel B
Use of a passive equilibration methodology to encapsulate cisplatin into preformed thermosensitive liposomes.
International journal of pharmaceutics 2008;349(1-2):38-46.
2008: Edwards Lincoln A; Woo Janet; Huxham Lynsey A; Verreault Maite; Dragowska Wieslawa H; Chiu Gigi; Rajput Ashish; Kyle Alastair H; Kalra Jessica; Yapp Donald; Yan Hong; Minchinton Andrew I; Huntsman David; Daynard Tim; Waterhouse Dawn N; Thiessen B; Dedhar Shoukat; Bally Marcel B
Suppression of VEGF secretion and changes in glioblastoma multiforme microenvironment by inhibition of integrin-linked kinase (ILK).
Molecular cancer therapeutics 2008;7(1):59-70.
2007: Dragowska Wieslawa H; Verreault Maïté; Yapp Donald T T; Warburton Corinna; Edwards Lincoln; Ramsay Euan C; Huxham Lynsey A; Minchinton Andrew I; Gelmon Karen; Bally Marcel B
Decreased levels of hypoxic cells in gefitinib treated ER+ HER-2 overexpressing MCF-7 breast cancer tumors are associated with hyperactivation of the mTOR pathway: therapeutic implications for combination therapy with rapamycin.
Breast cancer research and treatment 2007;106(3):319-31.
2007: To K; Zhao Y; Jiang H; Hu K; Wang M; Wu J; Lee C; Yokom D W; Stratford A L; Klinge U; Mertens P R; Chen C S; Bally M; Yapp D; Dunn S E
The phosphoinositide-dependent kinase-1 inhibitor 2-amino-N-[4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-acetamide (OSU-03012) prevents Y-box binding protein-1 from inducing epidermal growth factor receptor.
Molecular pharmacology 2007;72(3):641-52.
2007: Dos Santos Nancy; Allen Christine; Doppen Anne-Marie; Anantha Malathi; Cox Kelly A K; Gallagher Ryan C; Karlsson Goran; Edwards Katarina; Kenner Gail; Samuels Lacey; Webb Murray S; Bally Marcel B
Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding.
Biochimica et biophysica acta 2007;1768(6):1367-77.
2007: Zastre Jason; Anantha Malathi; Ramsay Euan; Bally Marcel
Irinotecan-cisplatin interactions assessed in cell-based screening assays: cytotoxicity, drug accumulation and DNA adduct formation in an NSCLC cell line.
Cancer chemotherapy and pharmacology 2007;60(1):91-102.
2007: Chiu Gigi N C; Edwards Lincoln A; Kapanen Anita I; Malinen Melina M; Dragowska Wieslawa H; Warburton Corinna; Chikh Ghania G; Fang Karen Y Y; Tan Sophia; Sy Jonathan; Tucker Catherine; Waterhouse Dawn N; Klasa Richard; Bally Marcel B
Modulation of cancer cell survival pathways using multivalent liposomal therapeutic antibody constructs.
Molecular cancer therapeutics 2007;6(3):844-55.
2007: Tardi Paul G; Gallagher Ryan C; Johnstone Sharon; Harasym Natashia; Webb Murray; Bally Marcel B; Mayer Lawrence D
Coencapsulation of irinotecan and floxuridine into low cholesterol-containing liposomes that coordinate drug release in vivo.
Biochimica et biophysica acta 2007;1768(3):678-87.
2007: Webb Murray S; Johnstone Sharon; Morris Tara J; Kennedy Allison; Gallagher Ryan; Harasym Natashia; Harasym Troy; Shew Clifford R; Tardi Paul; Dragowska Wieslawa H; Mayer Lawrence D; Bally Marcel B
In vitro and in vivo characterization of a combination chemotherapy formulation consisting of vinorelbine and phosphatidylserine.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2007;65(3):289-99.
2007: Ponce Ana M; Viglianti Benjamin L; Yu Daohai; Yarmolenko Pavel S; Michelich Charles R; Woo Janet; Bally Marcel B; Dewhirst Mark W
Magnetic resonance imaging of temperature-sensitive liposome release: drug dose painting and antitumor effects.
Journal of the National Cancer Institute 2007;99(1):53-63.
2006: Ramsay Euan; Alnajim Jehan; Anantha Malathi; Taggar Aman; Thomas Anitha; Edwards Katarina; Karlsson Göran; Webb Murray; Bally Marcel
Transition metal-mediated liposomal encapsulation of irinotecan (CPT-11) stabilizes the drug in the therapeutically active lactone conformation.
Pharmaceutical research 2006;23(12):2799-808.
2006: Cogswell Sebastian; Berger Stuart; Waterhouse Dawn; Bally Marcel B; Wasan Ellen K
A parenteral econazole formulation using a novel micelle-to-liposome transfer method: in vitro characterization and tumor growth delay in a breast cancer xenograft model.
Pharmaceutical research 2006;23(11):2575-85.
2006: Viglianti Benjamin L; Ponce Ana M; Michelich Charles R; Yu Daohai; Abraham Sheela A; Sanders Linda; Yarmolenko Pavel S; Schroeder Thies; MacFall James R; Barboriak Daniel P; Colvin O Michael; Bally Marcel B; Dewhirst Mark W
Chemodosimetry of in vivo tumor liposomal drug concentration using MRI.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2006;56(5):1011-8.
2006: Waterhouse Dawn N; Bally Marcel B
Temporal targeting in cancer: combined chemotherapy and antiangiogenic therapy.
Nanomedicine (London, England) 2006;1(3):359-63.
2006: Waterhouse D N; Gelmon K A; Klasa R; Chi K; Huntsman D; Ramsay E; Wasan E; Edwards L; Tucker C; Zastre J; Wang Y Z; Yapp D; Dragowska W; Dunn S; Dedhar S; Bally M B
Development and assessment of conventional and targeted drug combinations for use in the treatment of aggressive breast cancers.
Current cancer drug targets 2006;6(6):455-89.
2006: Verreault Maite; Webb Murray S; Ramsay Euan C; Bally Marcel B
Gene silencing in the development of personalized cancer treatment: the targets, the agents and the delivery systems.
Current gene therapy 2006;6(4):505-33.
2006: Taggar Amandeep S; Alnajim Jehan; Anantha Malathi; Thomas Anitha; Webb Murray; Ramsay Euan; Bally Marcel B
Copper-topotecan complexation mediates drug accumulation into liposomes.
Journal of controlled release : official journal of the Controlled Release Society 2006;114(1):78-88.
2006: Mayer Lawrence D; Harasym Troy O; Tardi Paul G; Harasym Natashia L; Shew Clifford R; Johnstone Sharon A; Ramsay Euan C; Bally Marcel B; Janoff Andrew S
Ratiometric dosing of anticancer drug combinations: controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice.
Molecular cancer therapeutics 2006;5(7):1854-63.
2006: Tucker Catherine A; Bebb Gwyn; Klasa Richard J; Chhanabhai Mukesh; Lestou Valia; Horsman Douglas E; Gascoyne Randy D; Wiestner Adrian; Masin Dana; Bally Marcel; Williams Michael E
Four human t(11;14)(q13;q32)-containing cell lines having classic and variant features of Mantle Cell Lymphoma.
Leukemia research 2006;30(4):449-57.
2006: Edwards Lincoln A; Verreault Maite; Thiessen Brian; Dragowska Wieslawa H; Hu Yanping; Yeung Juliana H F; Dedhar Shoukat; Bally Marcel B
Combined inhibition of the phosphatidylinositol 3-kinase/Akt and Ras/mitogen-activated protein kinase pathways results in synergistic effects in glioblastoma cells.
Molecular cancer therapeutics 2006;5(3):645-54.
2006: Troussard Armelle A; McDonald Paul C; Wederell Elizabeth D; Mawji Nasrin M; Filipenko Nolan R; Gelmon Karen A; Kucab Jill E; Dunn Sandra E; Emerman Joanne T; Bally Marcel B; Dedhar Shoukat
Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survival.
Cancer research 2006;66(1):393-403.
2005: Ramsay Euan C; Dos Santos Nancy; Dragowska Wieslawa H; Laskin Janessa J; Bally Marcel B
The formulation of lipid-based nanotechnologies for the delivery of fixed dose anticancer drug combinations.
Current drug delivery 2005;2(4):341-51.
2005: Waterhouse Dawn N; Denyssevych Tetyana; Hudon Norma; Chia Stephen; Gelmon Karen A; Bally Marcel B
Trastuzumab and liposomal Doxorubicin in the treatment of mcf-7 xenograft tumor-bearing mice: combination does not affect drug serum levels.
Pharmaceutical research 2005;22(6):915-22.
2005: Dos Santos Nancy; Waterhouse Dawn; Masin Dana; Tardi Paul G; Karlsson Göran; Edwards Katarina; Bally Marcel B
Substantial increases in idarubicin plasma concentration by liposome encapsulation mediates improved antitumor activity.
Journal of controlled release : official journal of the Controlled Release Society 2005;105(1-2):89-105.
2005: Chiu Gigi N C; Abraham Sheela A; Ickenstein Ludger M; Ng Rebecca; Karlsson Göran; Edwards Katarina; Wasan Ellen K; Bally Marcel B
Encapsulation of doxorubicin into thermosensitive liposomes via complexation with the transition metal manganese.
Journal of controlled release : official journal of the Controlled Release Society 2005;104(2):271-88.
2005: Edwards Lincoln A; Thiessen B; Dragowska Wieslawa H; Daynard Tim; Bally Marcel B; Dedhar Shoukat
Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth.
Oncogene 2005;24(22):3596-605.
2005: Abraham Sheela A; Waterhouse Dawn N; Mayer Lawrence D; Cullis Pieter R; Madden Thomas D; Bally Marcel B
The liposomal formulation of doxorubicin.
Methods in enzymology 2005;391():71-97.
2005: Waterhouse Dawn N; Madden Thomas D; Cullis Pieter R; Bally Marcel B; Mayer Lawrence D; Webb Murray S
Preparation, characterization, and biological analysis of liposomal formulations of vincristine.
Methods in enzymology 2005;391():40-57.
2004: Hu YanPing; Bebb Gwyn; Tan Sophia; Ng Rebecca; Yan Hong; Sartor Jason R; Mayer Lawrence D; Bally Marcel B
Antitumor efficacy of oblimersen Bcl-2 antisense oligonucleotide alone and in combination with vinorelbine in xenograft models of human non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(22):7662-70.
2004: Dragowska Wieslawa H; Warburton Corinna; Yapp Donald T T; Minchinton Andrew I; Hu Yanping; Waterhouse Dawn N; Gelmon Karen; Skov Kirsten; Woo Janet; Masin Dana; Huxham Lynsey A; Kyle Alastair H; Bally Marcel B
HER-2/neu overexpression increases the viable hypoxic cell population within solid tumors without causing changes in tumor vascularization.
Molecular cancer research : MCR 2004;2(11):606-19.
2004: Messerer Corrie Lynn; Ramsay Euan C; Waterhouse Dawn; Ng Rebecca; Simms Eva-Maria; Harasym Natashia; Tardi Paul; Mayer Lawrence D; Bally Marcel B
Liposomal irinotecan: formulation development and therapeutic assessment in murine xenograft models of colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(19):6638-49.
2004: Viglianti Benjamin L; Abraham Sheela A; Michelich Charles R; Yarmolenko Pavel S; MacFall James R; Bally Marcel B; Dewhirst Mark W
In vivo monitoring of tissue pharmacokinetics of liposome/drug using MRI: illustration of targeted delivery.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2004;51(6):1153-62.
2004: Schutze-Redelmeier Marie-Paule M; Kong Spencer; Bally Marcel B; Dutz Jan P
Antennapedia transduction sequence promotes anti tumour immunity to epicutaneously administered CTL epitopes.
Vaccine 2004;22(15-16):1985-91.
2004: Abraham Sheela A; Edwards Katarina; Karlsson Göran; Hudon Norma; Mayer Lawrence D; Bally Marcel B
An evaluation of transmembrane ion gradient-mediated encapsulation of topotecan within liposomes.
Journal of controlled release : official journal of the Controlled Release Society 2004;96(3):449-61.
2004: Warburton Corinna; Dragowska Wieslawa H; Gelmon Karen; Chia Stephen; Yan Hong; Masin Dana; Denyssevych Tetyana; Wallis Anne E; Bally Marcel B
Treatment of HER-2/neu overexpressing breast cancer xenograft models with trastuzumab (Herceptin) and gefitinib (ZD1839): drug combination effects on tumor growth, HER-2/neu and epidermal growth factor receptor expression, and viable hypoxic cell fraction.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(7):2512-24.
2004: Dos Santos Nancy; Cox Kelly A; McKenzie Cheryl A; van Baarda Floris; Gallagher Ryan C; Karlsson Goran; Edwards Katarina; Mayer Lawrence D; Allen Christine; Bally Marcel B
pH gradient loading of anthracyclines into cholesterol-free liposomes: enhancing drug loading rates through use of ethanol.
Biochimica et biophysica acta 2004;1661(1):47-60.
2004: Hu YanPing; Krishan Awtar; Nie WeiJia; Sridhar Kasi S; Mayer Lawrence D; Bally Marcel
Synergistic cytotoxicity of pyrazoloacridine with doxorubicin, etoposide, and topotecan in drug-resistant tumor cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(3):1160-9.
2004: Waterhouse Dawn N; Dragowska Wieslawa H; Gelmon Karen A; Mayer Lawrence D; Bally Marcel B
Pharmacodynamic behavior of liposomal antisense oligonucleotides targeting Her-2/neu and vascular endothelial growth factor in an ascitic MDA435/LCC6 human breast cancer model.
Cancer biology & therapy 2004;3(2):197-204.
2004: Abraham Sheela A; McKenzie Cheryl; Masin Dana; Ng Rebecca; Harasym Troy O; Mayer Lawrence D; Bally Marcel B
In vitro and in vivo characterization of doxorubicin and vincristine coencapsulated within liposomes through use of transition metal ion complexation and pH gradient loading.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(2):728-38.
2004: Edwards Lincoln A; Shabbits Jennifer A; Bally Marcel; Dedhar Shoukat
Integrin-linked kinase (ILK) in combination molecular targeting.
Cancer treatment and research 2004;119():59-75.
2003: Waterhouse Dawn N; Gelmon Karen A; Masin Dana; Bally Marcel B
Combining doxorubicin and liposomal anti-HER-2/NEU antisense oligodeoxynucleotides to treat HER-2/NEU-expressing MDA-MB-435 breast tumor model.
Journal of experimental therapeutics & oncology 2003;3(5):261-71.
2003: Hu Yanping; Bally Marcel; Dragowska Wieslawa H; Mayer Lawrence
Inhibition of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase enhances chemotherapeutic effects on H460 human non-small cell lung cancer cells through activation of apoptosis.
Molecular cancer therapeutics 2003;2(7):641-9.
2003: Li Wai Ming; Dragowska Wieslawa H; Bally Marcel B; Schutze-Redelmeier Marie Paule
Effective induction of CD8+ T-cell response using CpG oligodeoxynucleotides and HER-2/neu-derived peptide co-encapsulated in liposomes.
Vaccine 2003;21(23):3319-29.
2003: Chiu Gigi N C; Bally Marcel B; Mayer Lawrence D
Targeting of antibody conjugated, phosphatidylserine-containing liposomes to vascular cell adhesion molecule 1 for controlled thrombogenesis.
Biochimica et biophysica acta 2003;1613(1-2):115-21.
2003: Wong F M P; Harvie P; Zhang Y-P; Ramsay E C; Bally M B
Phosphatidylethanolamine mediated destabilization of lipid-based pDNA delivery systems.
International journal of pharmaceutics 2003;255(1-2):117-27.
2002: Wong F M P; MacAdam S A; Kim A; Oja C; Ramsay E C; Bally M B
A lipid-based delivery system for antisense oligonucleotides derived from a hydrophobic complex.
Journal of drug targeting 2002;10(8):615-23.
2002: Chikh Ghania G; Li Wai Ming; Schutze-Redelmeier Marie-Paule; Meunier Jean-Claude; Bally Marcel B
Attaching histidine-tagged peptides and proteins to lipid-based carriers through use of metal-ion-chelating lipids.
Biochimica et biophysica acta 2002;1567(1-2):204-12.
2002: Abraham Sheela Ann; Edwards Katarina; Karlsson Göran; MacIntosh Scott; Mayer Lawrence D; McKenzie Cheryl; Bally Marcel B
Formation of transition metal-doxorubicin complexes inside liposomes.
Biochimica et biophysica acta 2002;1565(1):41-54.
2002: Hu Qiang; Bally Marcel B; Madden Thomas D
Subcellular trafficking of antisense oligonucleotides and down-regulation of bcl-2 gene expression in human melanoma cells using a fusogenic liposome delivery system.
Nucleic acids research 2002;30(16):3632-41.
2002: Wasan Ellen K; Waterhouse Dawn; Sivak Olena; Bally Marcel B; Klasa Richard J; Wasan Kishor M
Plasma protein binding, lipoprotein distribution and uptake of free and lipid-associated BCL-2 antisense oligodeoxynucleotides (G3139) in human melanoma cells.
International journal of pharmaceutics 2002;241(1):57-64.
2002: Allen C; Dos Santos N; Gallagher R; Chiu G N C; Shu Y; Li W M; Johnstone S A; Janoff A S; Mayer L D; Webb M S; Bally M B
Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol).
Bioscience reports 2002;22(2):225-50.
2002: Guns Emma S; Denyssevych Tetyana; Dixon Ross; Bally Marcel B; Mayer Lawrence
Drug interaction studies between paclitaxel (Taxol) and OC144-093--a new modulator of MDR in cancer chemotherapy.
European journal of drug metabolism and pharmacokinetics 2002;27(2):119-26.
2002: Dos Santos Nancy; Mayer Lawrence D; Abraham Sheela A; Gallagher Ryan C; Cox Kelly A K; Tardi Paul G; Bally Marcel B
Improved retention of idarubicin after intravenous injection obtained for cholesterol-free liposomes.
Biochimica et biophysica acta 2002;1561(2):188-201.
2002: Li Wai Ming; Mayer Lawrence D; Bally Marcel B
Prevention of antibody-mediated elimination of ligand-targeted liposomes by using poly(ethylene glycol)-modified lipids.
The Journal of pharmacology and experimental therapeutics 2002;300(3):976-83.
2002: Chiu Gigi N C; Bally Marcel B; Mayer Lawrence D
Effects of phosphatidylserine on membrane incorporation and surface protection properties of exchangeable poly(ethylene glycol)-conjugated lipids.
Biochimica et biophysica acta 2002;1560(1-2):37-50.
2001: Chikh G G; Kong S; Bally M B; Meunier J C; Schutze-Redelmeier M P
Efficient delivery of Antennapedia homeodomain fused to CTL epitope with liposomes into dendritic cells results in the activation of CD8+ T cells.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(11):6462-70.
2001: Guns E S; Bullock P L; Reimer M L; Dixon R; Bally M; Mayer L D
Assessment of the involvement of CYP3A in the vitro metabolism of a new modulator of MDR in cancer chemotherapy, OC144-193, by human liver microsomes.
European journal of drug metabolism and pharmacokinetics 2001;26(4):273-82.
2001: Li W M; Bally M B; Schutze-Redelmeier M P
Enhanced immune response to T-independent antigen by using CpG oligodeoxynucleotides encapsulated in liposomes.
Vaccine 2001;20(1-2):148-57.
2001: Waterhouse D N; Dos Santos N; Mayer L D; Bally M B
Drug-drug interactions arising from the use of liposomal vincristine in combination with other anticancer drugs.
Pharmaceutical research 2001;18(9):1331-5.
2001: Hu Q; Shew C R; Bally M B; Madden T D
Programmable fusogenic vesicles for intracellular delivery of antisense oligodeoxynucleotides: enhanced cellular uptake and biological effects.
Biochimica et biophysica acta 2001;1514(1):1-13.
2001: Li W M; Xue L; Mayer L D; Bally M B
Intermembrane transfer of polyethylene glycol-modified phosphatidylethanolamine as a means to reveal surface-associated binding ligands on liposomes.
Biochimica et biophysica acta 2001;1513(2):193-206.
2001: Chikh G; Bally M; Schutze-Redelmeier M P
Characterization of hybrid CTL epitope delivery systems consisting of the Antennapedia homeodomain peptide vector formulated in liposomes.
Journal of immunological methods 2001;254(1-2):119-35.
2001: Johnstone S A; Masin D; Mayer L; Bally M B
Surface-associated serum proteins inhibit the uptake of phosphatidylserine and poly(ethylene glycol) liposomes by mouse macrophages.
Biochimica et biophysica acta 2001;1513(1):25-37.
2001: Wong M; Kong S; Dragowska W H; Bally M B
Oxazole yellow homodimer YOYO-1-labeled DNA: a fluorescent complex that can be used to assess structural changes in DNA following formation and cellular delivery of cationic lipid DNA complexes.
Biochimica et biophysica acta 2001;1527(1-2):61-72.
2001: Chiu G N; Bally M B; Mayer L D
Selective protein interactions with phosphatidylserine containing liposomes alter the steric stabilization properties of poly(ethylene glycol).
Biochimica et biophysica acta 2001;1510(1-2):56-69.
2001: Waterhouse D N; Tardi P G; Mayer L D; Bally M B
A comparison of liposomal formulations of doxorubicin with drug administered in free form: changing toxicity profiles.
Drug safety : an international journal of medical toxicology and drug experience 2001;24(12):903-20.
2000: Lim H J; Parr M J; Masin D; McIntosh N L; Madden T D; Zhang G; Johnstone S; Bally M B
Kupffer cells do not play a role in governing the efficacy of liposomal mitoxantrone used to treat a tumor model designed to assess drug delivery to liver.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(11):4449-60.
2000: Tardi P; Choice E; Masin D; Redelmeier T; Bally M; Madden T D
Liposomal encapsulation of topotecan enhances anticancer efficacy in murine and human xenograft models.
Cancer research 2000;60(13):3389-93.
2000: Klasa R J; Bally M B; Ng R; Goldie J H; Gascoyne R D; Wong F M
Eradication of human non-Hodgkin's lymphoma in SCID mice by BCL-2 antisense oligonucleotides combined with low-dose cyclophosphamide.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(6):2492-500.
2000: Harvie P; Wong F M; Bally M B
Use of poly(ethylene glycol)-lipid conjugates to regulate the surface attributes and transfection activity of lipid-DNA particles.
Journal of pharmaceutical sciences 2000;89(5):652-63.
2000: Lim H J; Masin D; McIntosh N L; Madden T D; Bally M B
Role of drug release and liposome-mediated drug delivery in governing the therapeutic activity of liposomal mitoxantrone used to treat human A431 and LS180 solid tumors.
The Journal of pharmacology and experimental therapeutics 2000;292(1):337-45.
1999: Wasan E K; Harvie P; Edwards K; Karlsson G; Bally M B
A multi-step lipid mixing assay to model structural changes in cationic lipoplexes used for in vitro transfection.
Biochimica et biophysica acta 1999;1461(1):27-46.
1999: Adlakha-Hutcheon G; Bally M B; Shew C R; Madden T D
Controlled destabilization of a liposomal drug delivery system enhances mitoxantrone antitumor activity.
Nature biotechnology 1999;17(8):775-9.
1999: Wong F M; Bally M B; Brooks D E
Electrostatically mediated interactions between cationic lipid-DNA particles and an anionic surface.
Archives of biochemistry and biophysics 1999;366(1):31-9.
1999: Reimer D L; Kong S; Monck M; Wyles J; Tam P; Wasan E K; Bally M B
Liposomal lipid and plasmid DNA delivery to B16/BL6 tumors after intraperitoneal administration of cationic liposome DNA aggregates.
The Journal of pharmacology and experimental therapeutics 1999;289(2):807-15.
1999: Gelmon K A; Tolcher A; Diab A R; Bally M B; Embree L; Hudon N; Dedhar C; Ayers D; Eisen A; Melosky B; Burge C; Logan P; Mayer L D
Phase I study of liposomal vincristine.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(2):697-705.
1998: Harvie P; Wong F M; Bally M B
Characterization of lipid DNA interactions. I. Destabilization of bound lipids and DNA dissociation.
Biophysical journal 1998;75(2):1040-51.
1998: Webb M S; Saxon D; Wong F M; Lim H J; Wang Z; Bally M B; Choi L S; Cullis P R; Mayer L D
Comparison of different hydrophobic anchors conjugated to poly(ethylene glycol): effects on the pharmacokinetics of liposomal vincristine.
Biochimica et biophysica acta 1998;1372(2):272-82.
1998: Wasan E K; Fairchild A; Bally M B
Cationic liposome--plasmid DNA complexes used for gene transfer retain a significant trapped volume.
Journal of pharmaceutical sciences 1998;87(1):9-14.
1998: Webb M S; Logan P; Kanter P M; St-Onge G; Gelmon K; Harasym T; Mayer L D; Bally M B
Preclinical pharmacology, toxicology and efficacy of sphingomyelin/cholesterol liposomal vincristine for therapeutic treatment of cancer.
Cancer chemotherapy and pharmacology 1998;42(6):461-70.
1998: Embree L; Gelmon K; Tolcher A; Hudon N; Heggie J; Dedhar C; Logan P; Bally M B; Mayer L D
Pharmacokinetic behavior of vincristine sulfate following administration of vincristine sulfate liposome injection.
Cancer chemotherapy and pharmacology 1998;41(5):347-52.
1997: Tardi P G; Swartz E N; Harasym T O; Cullis P R; Bally M B
An immune response to ovalbumin covalently coupled to liposomes is prevented when the liposomes used contain doxorubicin.
Journal of immunological methods 1997;210(2):137-48.
1997: Embree L; Gelmon K A; Tolcher A W; Hudon N J; Heggie J R; Dedhar C; Webb M S; Bally M B; Mayer L D
Validation of a high-performance liquid chromatographic assay method for quantification of total vincristine sulfate in human plasma following administration of vincristine sulfate liposome injection.
Journal of pharmaceutical and biomedical analysis 1997;16(4):675-87.
1997: Cullis P R; Hope M J; Bally M B; Madden T D; Mayer L D; Fenske D B
Influence of pH gradients on the transbilayer transport of drugs, lipids, peptides and metal ions into large unilamellar vesicles.
Biochimica et biophysica acta 1997;1331(2):187-211.
1997: Reimer D L; Kong S; Bally M B
Analysis of cationic liposome-mediated interactions of plasmid DNA with murine and human melanoma cells in vitro.
The Journal of biological chemistry 1997;272(31):19480-7.
1997: Lim H J; Masin D; Madden T D; Bally M B
Influence of drug release characteristics on the therapeutic activity of liposomal mitoxantrone.
The Journal of pharmacology and experimental therapeutics 1997;281(1):566-73.
1997: Mayer L D; Dougherty G; Harasym T O; Bally M B
The role of tumor-associated macrophages in the delivery of liposomal doxorubicin to solid murine fibrosarcoma tumors.
The Journal of pharmacology and experimental therapeutics 1997;280(3):1406-14.
1997: Parr M J; Masin D; Cullis P R; Bally M B
Accumulation of liposomal lipid and encapsulated doxorubicin in murine Lewis lung carcinoma: the lack of beneficial effects by coating liposomes with poly(ethylene glycol).
The Journal of pharmacology and experimental therapeutics 1997;280(3):1319-27.
1997: Zhang Y P; Reimer D L; Zhang G; Lee P H; Bally M B
Self-assembling DNA-lipid particles for gene transfer.
Pharmaceutical research 1997;14(2):190-6.
1997: Harasym T O; Cullis P R; Bally M B
Intratumor distribution of doxorubicin following i.v. administration of drug encapsulated in egg phosphatidylcholine/cholesterol liposomes.
Cancer chemotherapy and pharmacology 1997;40(4):309-17.
1997: Chang C W; Barber L; Ouyang C; Masin D; Bally M B; Madden T D
Plasma clearance, biodistribution and therapeutic properties of mitoxantrone encapsulated in conventional and sterically stabilized liposomes after intravenous administration in BDF1 mice.
British journal of cancer 1997;75(2):169-77.
1996: Wong F M; Reimer D L; Bally M B
Cationic lipid binding to DNA: characterization of complex formation.
Biochemistry 1996;35(18):5756-63.
1996: Wasan E K; Reimer D L; Bally M B
Plasmid DNA is protected against ultrasonic cavitation-induced damage when complexed to cationic liposomes.
Journal of pharmaceutical sciences 1996;85(4):427-33.
1996: Boman N L; Tron V A; Bally M B; Cullis P R
Vincristine-induced dermal toxicity is significantly reduced when the drug is given in liposomes.
Cancer chemotherapy and pharmacology 1996;37(4):351-5.
1995: Longman S A; Tardi P G; Parr M J; Choi L; Cullis P R; Bally M B
Accumulation of protein-coated liposomes in an extravascular site: influence of increasing carrier circulation lifetimes.
The Journal of pharmacology and experimental therapeutics 1995;275(3):1177-84.
1995: Choice E; Masin D; Bally M B; Meloche M; Madden T D
Liposomal cyclosporine. Comparison of drug and lipid carrier pharmacokinetics and biodistribution.
Transplantation 1995;60(9):1006-11.
1995: Reimer D L; Zhang Y; Kong S; Wheeler J J; Graham R W; Bally M B
Formation of novel hydrophobic complexes between cationic lipids and plasmid DNA.
Biochemistry 1995;34(39):12877-83.
1995: Webb M S; Harasym T O; Masin D; Bally M B; Mayer L D
Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour models.
British journal of cancer 1995;72(4):896-904.
1995: Webb M S; Wheeler J J; Bally M B; Mayer L D
The cationic lipid stearylamine reduces the permeability of the cationic drugs verapamil and prochlorperazine to lipid bilayers: implications for drug delivery.
Biochimica et biophysica acta 1995;1238(2):147-55.
1995: Mayer L D; Masin D; Nayar R; Boman N L; Bally M B
Pharmacology of liposomal vincristine in mice bearing L1210 ascitic and B16/BL6 solid tumours.
British journal of cancer 1995;71(3):482-8.
1995: Harasym T O; Tardi P; Longman S A; Ansell S M; Bally M B; Cullis P R; Choi L S
Poly(ethylene glycol)-modified phospholipids prevent aggregation during covalent conjugation of proteins to liposomes.
Bioconjugate chemistry 1995;6(2):187-94.
1995: Longman S A; Cullis P R; Choi L; de Jong G; Bally M B
A two-step targeting approach for delivery of doxorubicin-loaded liposomes to tumour cells in vivo.
Cancer chemotherapy and pharmacology 1995;36(2):91-101.
1994: Wheeler J J; Wong K F; Ansell S M; Masin D; Bally M B
Polyethylene glycol modified phospholipids stabilize emulsions prepared from triacylglycerol.
Journal of pharmaceutical sciences 1994;83(11):1558-64.
1994: Boman N L; Masin D; Mayer L D; Cullis P R; Bally M B
Liposomal vincristine which exhibits increased drug retention and increased circulation longevity cures mice bearing P388 tumors.
Cancer research 1994;54(11):2830-3.
1994: Bally M B; Masin D; Nayar R; Cullis P R; Mayer L D
Transfer of liposomal drug carriers from the blood to the peritoneal cavity of normal and ascitic tumor-bearing mice.
Cancer chemotherapy and pharmacology 1994;34(2):137-46.
1993: Parr M J; Bally M B; Cullis P R
The presence of GM1 in liposomes with entrapped doxorubicin does not prevent RES blockade.
Biochimica et biophysica acta 1993;1168(2):249-52.
1993: Mayer L D; Nayar R; Thies R L; Boman N L; Cullis P R; Bally M B
Identification of vesicle properties that enhance the antitumour activity of liposomal vincristine against murine L1210 leukemia.
Cancer chemotherapy and pharmacology 1993;33(1):17-24.
1991: Cullis P R; Bally M B; Madden T D; Mayer L D; Hope M J
pH gradients and membrane transport in liposomal systems.
Trends in biotechnology 1991;9(8):268-72.
1990: Loughrey H C; Wong K F; Choi L S; Cullis P R; Bally M B
Protein-liposome conjugates with defined size distributions.
Biochimica et biophysica acta 1990;1028(1):73-81.
1990: Loughrey H C; Choi L S; Cullis P R; Bally M B
Optimized procedures for the coupling of proteins to liposomes.
Journal of immunological methods 1990;132(1):25-35.
1990: Loughrey H C; Bally M B; Reinish L W; Cullis P R
The binding of phosphatidylglycerol liposomes to rat platelets is mediated by complement.
Thrombosis and haemostasis 1990;64(1):172-6.
1990: Thies R L; Cowens D W; Cullis P R; Bally M B; Mayer L D
Method for rapid separation of liposome-associated doxorubicin from free doxorubicin in plasma.
Analytical biochemistry 1990;188(1):65-71.
1990: Mayer L D; Tai L C; Bally M B; Mitilenes G N; Ginsberg R S; Cullis P R
Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients.
Biochimica et biophysica acta 1990;1025(2):143-51.
1990: Bally M B; Nayar R; Masin D; Hope M J; Cullis P R; Mayer L D
Liposomes with entrapped doxorubicin exhibit extended blood residence times.
Biochimica et biophysica acta 1990;1023(1):133-9.
1990: Madden T D; Harrigan P R; Tai L C; Bally M B; Mayer L D; Redelmeier T E; Loughrey H C; Tilcock C P; Reinish L W; Cullis P R
The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a survey.
Chemistry and physics of lipids 1990;53(1):37-46.
1990: Mayer L D; Bally M B; Loughrey H; Masin D; Cullis P R
Liposomal vincristine preparations which exhibit decreased drug toxicity and increased activity against murine L1210 and P388 tumors.
Cancer research 1990;50(3):575-9.
1990: Bally M B; Nayar R; Masin D; Cullis P R; Mayer L D
Studies on the myelosuppressive activity of doxorubicin entrapped in liposomes.
Cancer chemotherapy and pharmacology 1990;27(1):13-9.
1989: Mayer L D; Tai L C; Ko D S; Masin D; Ginsberg R S; Cullis P R; Bally M B
Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice.
Cancer research 1989;49(21):5922-30.
1989: Redelmeier T E; Mayer L D; Wong K F; Bally M B; Cullis P R
Proton flux in large unilamellar vesicles in response to membrane potentials and pH gradients.
Biophysical journal 1989;56(2):385-93.
1989: Doerschuk C M; Gie R P; Bally M B; Cullis P R; Reinish L W
Platelet distribution in rabbits following infusion of liposomes.
Thrombosis and haemostasis 1989;61(3):392-6.
1989: Balazsovits J A; Mayer L D; Bally M B; Cullis P R; McDonell M; Ginsberg R S; Falk R E
Analysis of the effect of liposome encapsulation on the vesicant properties, acute and cardiac toxicities, and antitumor efficacy of doxorubicin.
Cancer chemotherapy and pharmacology 1989;23(2):81-6.
1988: Reinish L W; Bally M B; Loughrey H C; Cullis P R
Interactions of liposomes and platelets.
Thrombosis and haemostasis 1988;60(3):518-23.
1988: Bally M B; Mayer L D; Loughrey H; Redelmeier T; Madden T D; Wong K; Harrigan P R; Hope M J; Cullis P R
Dopamine accumulation in large unilamellar vesicle systems induced by transmembrane ion gradients.
Chemistry and physics of lipids 1988;47(2):97-107.
1987: Loughrey H; Bally M B; Cullis P R
A non-covalent method of attaching antibodies to liposomes.
Biochimica et biophysica acta 1987;901(1):157-60.
1985: Madden T D; Bally M B; Hope M J; Cullis P R; Schieren H P; Janoff A S
Protection of large unilamellar vesicles by trehalose during dehydration: retention of vesicle contents.
Biochimica et biophysica acta 1985;817(1):67-74.

Sign-in to see more